PCI Biotech
CONTACT US
ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION
TECHNOLOGY PIPELINE PARTNERING
INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE
ABOUT US ABOUT PCI BIOTECH BOARD OF DIRECTORS MANAGEMENT COMPANY PRESENTATION WHAT WE DO TECHNOLOGY PIPELINE PARTNERING INVESTORS INVESTORS NEWS REPORTS AND PRESENTATIONS SHARE INFORMATION GENERAL MEETING INFORMATION FINANCIAL CALENDAR CORPORATE GOVERNANCE AND CSR NOMINATION COMMITTEE CONTACT US
PCI Biotech
 

NEWS

News archive
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
 
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
Ronny SkuggedalOctober 13, 2023
European patent for mRNA delivery with fimaNAc
Ronny SkuggedalSeptember 7, 2023
PCI Biotech: Employee share option scheme
Ronny SkuggedalSeptember 4, 2023
Write-down of share capital registered
Ronny SkuggedalSeptember 1, 2023
PCI Biotech first half 2023 interim results
Ronny SkuggedalAugust 31, 2023
Invitation to first half interim 2023 results presentation
Ronny SkuggedalAugust 25, 2023
Minutes from Annual General Meeting 2023
Ronny SkuggedalMay 25, 2023
PCI Biotech interim Q1 2023 results
Ronny SkuggedalMay 12, 2023
Invitation to Q1 2023 results presentation
Ronny SkuggedalMay 9, 2023
Notice of Annual General Meeting 2023
Ronny SkuggedalMay 4, 2023
PCI Biotech Holding ASA: Annual Report 2022
Ronny SkuggedalApril 28, 2023
PCI Biotech interim Q4 2022 results
Ronny SkuggedalFebruary 17, 2023
Invitation to Q4 2022 results presentation
Ronny SkuggedalFebruary 13, 2023

Privacy policy I Contact us
©COPYRIGHT PCI BIOTECH. ALL RIGHTS RESERVED